|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2004-3-25
|
|
pubmed:abstractText |
Interferon-beta (IFNbeta) has multiple antitumor effects; however, its use has been limited by its short half-life in vivo. This limitation may be overcome by IFNbeta gene therapy. We evaluated adenovirus-IFNbeta therapy in an immunocompetent mouse model of carcinomatosis.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0039-6060
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
135
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
427-36
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:15041967-Adenoviridae,
pubmed-meshheading:15041967-Animals,
pubmed-meshheading:15041967-Antineoplastic Agents,
pubmed-meshheading:15041967-Cell Line, Tumor,
pubmed-meshheading:15041967-Female,
pubmed-meshheading:15041967-Gene Therapy,
pubmed-meshheading:15041967-Genetic Vectors,
pubmed-meshheading:15041967-Immunocompetence,
pubmed-meshheading:15041967-Interferon-beta,
pubmed-meshheading:15041967-Mice,
pubmed-meshheading:15041967-Mice, Inbred C3H,
pubmed-meshheading:15041967-Models, Animal,
pubmed-meshheading:15041967-Ovarian Neoplasms,
pubmed-meshheading:15041967-Teratoma
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Interferon-beta gene therapy improves survival in an immunocompetent mouse model of carcinomatosis.
|
|
pubmed:affiliation |
Department of Surgery, University of Pennsylvania, 3400 Spruce Street, 4 Silverstein, Philadelphia, PA 19104, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
